Primary care physician attitudes and perceptions of the impact of FDA-proposed REMS policy on prescription of extended-release and long-acting opioids

With increasing numbers of patients experiencing chronic pain, opioid therapy is becoming more common, leading to increases in concern about issues of abuse, diversion, and misuse. Further, the US Food and Drug Administration recently released a statement notifying sponsors and manufacturers of exte...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinas, Gregory D, Robinson, Caroline O, Abdolrasulnia, Maziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474156/
https://www.ncbi.nlm.nih.gov/pubmed/23091393
http://dx.doi.org/10.2147/JPR.S35798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474156/
https://www.ncbi.nlm.nih.gov/pubmed/23091393
http://dx.doi.org/10.2147/JPR.S35798

Ejemplares similares